BP-SGC @EC2603A(19728.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
BP-SGC @EC2603A
19728.HK
News
View More

This afternoon, appointment reservations opened for the pilot program of internet diagnosis and treatment in Beijing

Beijing launched a pilot program for online diagnosis and treatment services on January 31, starting with three pediatric subspecialties at Beijing Children's Hospital and Capital Institute of Pediatrics. This service provides online pre-consultation, online diagnosis and treatment, and medication delivery for first-time patients, aiming to ensure the safety and quality of diagnosis and treatment. Doctors can complete the initial diagnosis and issue prescriptions via the internet

Wallstreetcn·
HK
01099
+0.10%
Wallstreetcn·
HK
01099
+0.10%

Sinopharm Group Files Director List with HKEX

Sinopharm Group Co. Ltd. has filed an updated list of directors with the Hong Kong Stock Exchange, detailing their roles and committee memberships. The board includes Non-Executive, Executive, and Independent Non-Executive Directors, with Jin Bin as Chairman. The filing reflects a broad distribution of responsibilities across governance, strategy, compliance, remuneration, and nomination functions. This information was published by Sinopharm Group via the Hong Kong Stock Exchange's Issuer Information Service.

Reuters·
HK
01099
+0.10%
Reuters·
HK
01099
+0.10%

Sinopharm Group (SEHK:1099): Valuation Check After Renewing Shanghai Henlius Distribution Partnership

Sinopharm Group's renewed distribution partnership with Shanghai Henlius Biotech extends their collaboration until 2028. Despite a modest recent share price increase, Sinopharm's long-term returns remain strong. The company's current price-to-earnings ratio of 8.1x suggests undervaluation compared to industry averages. However, a DCF model indicates a fair value of HK$15.36, suggesting potential overvaluation. Risks include policy changes and slower procurement growth. Investors are encouraged to explore further investment opportunities and assess potential mispricing in the market.

Simplywall·
HK
01099
+0.10%
Simplywall·
HK
01099
+0.10%

Sinopharm Group Co. Ltd. Announces Date for Extraordinary General Meeting

Sinopharm Group Co. Ltd. will hold an extraordinary general meeting on December 19, 2025, in Shanghai, China. Shareholders will vote on appointing Mr. Jin Bin and Ms. Li Ying as non-executive Directors of the Board, with authorization for the Board to determine their remuneration and service contracts. This announcement was published by Sinopharm Group via the Hong Kong Stock Exchange's Issuer Information Service.

Reuters·
HK
01099
+0.10%
Reuters·
HK
01099
+0.10%

Shanghai Henlius Biotech Renews Distribution Agreement with Sinopharm

Shanghai Henlius Biotech Inc. has renewed its distribution agreement with Sinopharm Group, signing a new framework on December 3, 2025. This extends their partnership, with transactions conducted in the ordinary course of business. An Independent Board Committee will advise shareholders on the agreement's fairness. The news was generated by Public Technologies using AI and is for informational purposes only.

Reuters·
HK
01099
+0.10%
HK
02696
+4.10%
Reuters·
HK
01099
+0.10%
HK
02696
+4.10%
© 2026 Longbridge｜Disclaimer